Editas Medicine, Inc. — Director's Dealing 2021

Nov 11, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Editas Medicine, Inc. (EDIT)
CIK: 0001650664
Period of Report: 2021-11-09

Reporting Person: Eaton Bruce (EVP, Chief Business Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-09	Common Stock	S	287	$40.61	Disposed	28026	Direct

Footnotes

F1: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on November 6, 2021. The sale does not represent a discretionary trade by the Reporting Person.